In addition, this pathway is regulated by the androgen receptor in prostate cancer cells [77], suggesting that the hyperandrogenism characteristic of PCOS could modulate the gene expression and phenotype of ABD-derived ASCs. The gene discussed is AR; the disease is prostate carcinoma.